Czech National Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9M Buy
61,813
+1,705
+3% +$632K 0.13% 130
2026
Q1
$17.6M Buy
60,108
+1,506
+3% +$495K 0.12% 170
2025
Q4
$20.5M Buy
58,602
+1,411
+2% +$477K 0.13% 131
2025
Q3
$18.5M Buy
57,191
+1,965
+4% +$611K 0.13% 145
2025
Q2
$21.5M Buy
55,226
+1,957
+4% +$787K 0.17% 117
2025
Q1
$23.2M Buy
53,269
+2,983
+6% +$1.2M 0.21% 95
2024
Q4
$18.6M Buy
50,286
+3,049
+6% +$1.28M 0.17% 109
2024
Q3
$24.6M Buy
47,237
+2,947
+7% +$1.57M 0.25% 76
2024
Q2
$24M Buy
44,290
+2,949
+7% +$1.56M 0.27% 71
2024
Q1
$21.4M Buy
41,341
+183
+0.4% +$91K 0.28% 72
2023
Q4
$19.4M Sell
41,158
-28
-0.1% -$12.9K 0.28% 74
2023
Q3
$17.9M Buy
41,186
+13,123
+47% +$5.95M 0.29% 76
2023
Q2
$12.5M Sell
28,063
-72
-0.3% -$33.2K 0.28% 75
2023
Q1
$12.9M Buy
28,135
+180
+0.6% +$85.7K 0.32% 70
2022
Q4
$14.3M Buy
27,955
+63
+0.2% +$32K 0.38% 61
2022
Q3
$12.7M Buy
+27,892
New +$13.3M 0.36% 58

Other funds holding ELV

Czech National Bank's ELV Position: Q2 2026 in Review

Czech National Bank increased its Elevance Health (ELV) stake by 2.8% in Q2 2026, buying an estimated $632K and bringing the position to 61,813 shares worth $23.9M. The position accounts for 0.13% of the portfolio, ranked #130.

Czech National Bank first reported a position in ELV in Q3 2022 and has held it in 16 quarters since. The position peaked at $24.6M in Q3 2024. 601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Czech National Bank held 61,813 shares of Elevance Health worth $23.9M as of Q2 2026.
  • Czech National Bank bought 1,705 Elevance Health shares in Q2 2026, an estimated $632K.
  • Elevance Health made up 0.13% of Czech National Bank's portfolio in Q2 2026, its #130 holding.
  • Czech National Bank first reported a position in Elevance Health in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Elevance Health position peaked at $24.6M in Q3 2024.
  • 601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.